EGFR AND HER2: AN ONCOGENIC ALLIANCE

被引:0
|
作者
Yarden, Y. [1 ]
机构
[1] Weizmann Inst Sci, IL-76100 Rehovot, Israel
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [1] The HER2 and EGFR alliance in cancer: defects in system control
    Yarden, Y.
    EJC SUPPLEMENTS, 2010, 8 (05): : 2 - 3
  • [2] EGFR and HER2: Systemic approaches to oncogenic networks and to pharmaceutical perturbations
    Yarden, Y.
    BREAST, 2009, 18 : S3 - S3
  • [3] Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2
    Foster, Scott A.
    Whalen, Daniel M.
    Oezen, Aysxeguel
    Wongchenko, Matthew J.
    Yin, JianPing
    Yen, Ivana
    Schaefer, Gabriele
    Mayfield, John D.
    Chmielecki, Juliann
    Stephens, Philip J.
    Albacker, Lee A.
    Yan, Yibing
    Song, Kyung
    Hatzivassiliou, Georgia
    Eigenbrot, Charles
    Yu, Christine
    Shaw, Andrey S.
    Manning, Gerard
    Skelton, Nicholas J.
    Hymowitz, Sarah G.
    Malek, Shiva
    CANCER CELL, 2016, 29 (04) : 477 - 493
  • [4] Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2
    Bae, Kieun
    Kim, Jin Hee
    Lee, Ja Young
    Kong, Sun-Young
    Kim, Yun-Hee
    Kim, Sunshin
    Yoon, Kyong-Ah
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [5] Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors
    Kosaka, Takayuki
    Tanizaki, Junko
    Paranal, Raymond M.
    Endoh, Hideki
    Lydon, Christine
    Capelletti, Marzia
    Repellin, Claire E.
    Choi, Jihyun
    Ogino, Atsuko
    Calles, Antonio
    Ercan, Dalia
    Redig, Amanda J.
    Bahcall, Magda
    Oxnard, Geoffrey R.
    Eck, Michael J.
    Janne, Pasi A.
    CANCER RESEARCH, 2017, 77 (10) : 2712 - 2721
  • [6] EGFR, HER2 and VEGF pathways
    Press, Michael F.
    Lenz, Heinz-Josef
    DRUGS, 2007, 67 (14) : 2045 - 2075
  • [7] Activation mechanism of oncogenic C-helix shifting mutations in BRAF, EGFR, and HER2
    Foster, Scott
    Whalen, Dan
    Ozen, Aysegul
    Wongchenko, Matt
    Yin, JianPing
    Yen, Ivana
    Schaefer, Gabriele
    Mayfield, John
    Chmielecki, Juliann
    Stephens, Phil
    Albacker, Lee
    Yan, Yibing
    Song, Kyung
    Hatzivassiliou, Georgia
    Eigenbrot, Charles
    Yu, Christine
    Shaw, Andrey
    Manning, Gerard
    Skelton, Nicholas
    Hymowitz, Sarah
    Malek, Shiva
    CANCER RESEARCH, 2016, 76
  • [8] EGFR negates the proliferative effect of oncogenic HER2 in MDA-MB-231 cells
    Oh, Sunhwa
    Ju, Ji-hyun
    Yang, Wonseok
    Lee, Kyung-min
    Nam, KeeSoo
    Shin, Incheol
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2015, 575 : 69 - 76
  • [9] HER2 aberrations and other oncogenic drivers
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 : S66 - S70
  • [10] Oncogenic HER2 fusions in gastric cancer
    De-Hua Yu
    Lili Tang
    Hua Dong
    Zhengwei Dong
    Lianhai Zhang
    Jiangang Fu
    Xinying Su
    Tianwei Zhang
    Haihua Fu
    Lu Han
    Liang Xie
    Hao Chen
    Ziliang Qian
    Guanshan Zhu
    Jia Wang
    Qingqing Ye
    Jingchuan Zhang
    Xiaolu Yin
    Xiaolin Zhang
    Jiafu Ji
    Qunsheng Ji
    Journal of Translational Medicine, 13